The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An immune-related gene expression profile to predict the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the phase II randomized AtezoTRIBE study.
 
Alessandra Boccaccino
No Relationships to Disclose
 
Robert Seitz
Employment - OncoCyte
Leadership - OncoCyte
Stock and Other Ownership Interests - OncoCyte
Consulting or Advisory Role - Thermo Fisher Scientific
 
Mirella Giordano
No Relationships to Disclose
 
Daniele Rossini
Speakers' Bureau - MSD Oncology
 
Margherita Ambrosini
No Relationships to Disclose
 
Lisa Salvatore
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Bayer; Celgene; Merck Serono; Roche; Sanofi; SERVIER
 
Kimberly McGregor
Employment - Foundation Medicine; OncoCyte
Stock and Other Ownership Interests - OncoCyte; Roche/Genentech
 
Francesca Bergamo
No Relationships to Disclose
 
Veronica Conca
No Relationships to Disclose
 
Leonardo Provenzano
No Relationships to Disclose
 
Stefano Tamberi
No Relationships to Disclose
 
Matteo Ramundo
No Relationships to Disclose
 
Giampaolo Tortora
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Celgene; Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Cosimo Rasola
No Relationships to Disclose
 
Douglas Teller Ross
No Relationships to Disclose
 
Alessandro Passardi
No Relationships to Disclose
 
Tyler J. Nielsen
Employment - OncoCyte
Patents, Royalties, Other Intellectual Property - International Appln. No.: PCT/US21/44240 Title: CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS Applicant: Oncocyte Corporation Filed: August 2, 2021 Earliest Priority Claim: US Appln. No. 63/060,321; Filed: August 3, 2020 (Inst)
 
Matthew Gordon Varga
No Relationships to Disclose
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Pierre Fabre; Roche
Speakers' Bureau - Merck; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Carlotta Antoniotti
No Relationships to Disclose